会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • HEART FAILURE MONITORING
    • 心力衰竭监测
    • US20120253207A1
    • 2012-10-04
    • US13436408
    • 2012-03-30
    • Shantanu SarkarJodi L. RedemskeEduardo N. WarmanDouglas A. HettrickKevin T. Ousdigian
    • Shantanu SarkarJodi L. RedemskeEduardo N. WarmanDouglas A. HettrickKevin T. Ousdigian
    • A61B5/0205
    • A61B5/0006A61B5/0004A61B5/7275G06F19/3418G16H40/40G16H50/30
    • Techniques for transmitting diagnostic information stored in an implantable medical device (IMD) based on patient hospitalization are described. For example, the IMD may transmit higher resolution diagnostic information to a clinician and/or an external device during a hospitalization period to aid the clinician in evaluating heart failure treatment and when discharge is proper. This higher resolution diagnostic information may include one or more patient metrics automatically generated and transmitted by the IMD at least once every two hours. During a post-hospitalization period, the IMD may transmit lower resolution diagnostic information to a clinician that indicates a risk level of re-hospitalization. The lower resolution diagnostic information may include the risk level and/or patient metrics once a day, for example. In this manner, the IMD transmitted diagnostic information may be tailored to the specific heart failure monitoring needed by the patient.
    • 描述了基于患者住院时间传送存储在可植入医疗装置(IMD)中的诊断信息的技术。 例如,IMD可以在住院期间向临床医师和/或外部设备传送更高分辨率的诊断信息,以帮助临床医师评价心力衰竭治疗以及放电是否合适。 该更高分辨率的诊断信息可以包括由IMD自动生成和发送的至少每两小时一次的一个或多个患者度量。 在住院后期间,IMD可以向临床医生传递较低分辨率的诊断信息,指示重新住院的风险水平。 例如,较低分辨率诊断信息可以包括一天一次的风险水平和/或患者度量。 以这种方式,IMD传输的诊断信息可以针对患者所需的特定心力衰竭监测。
    • 6. 发明申请
    • REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS
    • 减少不合理的非精神病人的治疗方法
    • US20110172727A1
    • 2011-07-14
    • US13053625
    • 2011-03-22
    • Kevin T. Ousdigian
    • Kevin T. Ousdigian
    • A61N1/365
    • A61N1/37252A61B5/0464A61B5/7264A61N1/3621A61N1/3956A61N1/3987
    • An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).
    • 植入式医疗器械(IMD)识别疑似非致死性室性心律失常,并采取一项或多项行动来回应识别,以避免或延迟除颤或复律性休克的传播。 IMD采用间隔数来检测(NID)阈值以检测室性心律失常。 当满足NID阈值时,即使满足NID阈值,IMD确定心室节律是否是怀疑的非致命节律。 在一些实施例中,响应于将节律识别为怀疑非致命节律,IMD增加NID阈值,即扩展检测时间,并且监测随后的心室搏动以确定在检测到之前是否满足增加的NID阈值 室性心律失常和输送治疗。 IMD可以通过例如比较心室中心周期长度(VCL)与中位心房周期长度(ACL)来确定节律是否是怀疑是非致死性心律失常。